Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-SART3 antibody (40-120 aa) (STJ190220) | Login | Anti-SART3 antibody (40-120 aa) (STJ190220) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDGFRL antibody (50-130 aa) (STJ190221) | Login | Anti-PDGFRL antibody (50-130 aa) (STJ190221) | ||||||||||||||||
|
||||||||||||||||||
Anti-PCBP1 antibody (30-110 aa) (STJ190222) | Login | Anti-PCBP1 antibody (30-110 aa) (STJ190222) | ||||||||||||||||
|
||||||||||||||||||
Anti-PCBP2 antibody (30-110 aa) (STJ190223) | Login | Anti-PCBP2 antibody (30-110 aa) (STJ190223) | ||||||||||||||||
|
||||||||||||||||||
Anti-TAL2 antibody (1-80 aa) (STJ190224) | Login | Anti-TAL2 antibody (1-80 aa) (STJ190224) | ||||||||||||||||
|
||||||||||||||||||
Anti-AGK antibody (330-410 aa) (STJ190226) | Login | Anti-AGK antibody (330-410 aa) (STJ190226) | ||||||||||||||||
|
||||||||||||||||||
Anti-CT83 antibody (30-110 aa) (STJ190227) | Login | Anti-CT83 antibody (30-110 aa) (STJ190227) | ||||||||||||||||
|
||||||||||||||||||
Anti-AATK antibody (1110-1190 aa) (STJ190230) | Login | Anti-AATK antibody (1110-1190 aa) (STJ190230) | ||||||||||||||||
|
||||||||||||||||||
Anti-BRSK2 antibody (320-400 aa) (STJ190235) | Login | Anti-BRSK2 antibody (320-400 aa) (STJ190235) | ||||||||||||||||
|
||||||||||||||||||
Anti-TNFAIP8L1 antibody (40-120 aa) (STJ190238) | Login | Anti-TNFAIP8L1 antibody (40-120 aa) (STJ190238) | ||||||||||||||||
|
||||||||||||||||||
Anti-KAT6B antibody (1170-1250 aa) (STJ190240) | Login | Anti-KAT6B antibody (1170-1250 aa) (STJ190240) | ||||||||||||||||
|
||||||||||||||||||
Anti-GTF2H4 antibody (380-460 aa) (STJ190243) | Login | Anti-GTF2H4 antibody (380-460 aa) (STJ190243) | ||||||||||||||||
|
||||||||||||||||||
Anti-ZMAT3 antibody (210-290 aa) (STJ190251) | Login | Anti-ZMAT3 antibody (210-290 aa) (STJ190251) | ||||||||||||||||
|
||||||||||||||||||
Anti-APOBEC3C antibody (10-90 aa) (STJ190253) | Login | Anti-APOBEC3C antibody (10-90 aa) (STJ190253) | ||||||||||||||||
|
||||||||||||||||||
Anti-IBTK antibody (410-490 aa) (STJ190257) | Login | Anti-IBTK antibody (410-490 aa) (STJ190257) | ||||||||||||||||
|
||||||||||||||||||
Anti-MRTFB antibody (500-580 aa) (STJ190259) | Login | Anti-MRTFB antibody (500-580 aa) (STJ190259) | ||||||||||||||||
|
||||||||||||||||||
Anti-KMT2B antibody (1060-1140 aa) (STJ190261) | Login | Anti-KMT2B antibody (1060-1140 aa) (STJ190261) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAST1 antibody (300-380 aa) (STJ190265) | Login | Anti-MAST1 antibody (300-380 aa) (STJ190265) | ||||||||||||||||
|
||||||||||||||||||
Anti-THRAP3 antibody (110-190 aa) (STJ190266) | Login | Anti-THRAP3 antibody (110-190 aa) (STJ190266) | ||||||||||||||||
|
||||||||||||||||||
Anti-WNK2 antibody (1120-1200 aa) (STJ190267) | Login | Anti-WNK2 antibody (1120-1200 aa) (STJ190267) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAFB antibody (180-260 aa) (STJ190268) | Login | Anti-MAFB antibody (180-260 aa) (STJ190268) | ||||||||||||||||
|
||||||||||||||||||
Anti-DNMT3A antibody (10-90 aa) (STJ190270) | Login | Anti-DNMT3A antibody (10-90 aa) (STJ190270) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDC123 antibody (270-350 aa) (STJ190274) | Login | Anti-CDC123 antibody (270-350 aa) (STJ190274) | ||||||||||||||||
|
||||||||||||||||||
Anti-CD320 antibody (100-180 aa) (STJ190275) | Login | Anti-CD320 antibody (100-180 aa) (STJ190275) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDK3 antibody (10-90 aa) (STJ190276) | Login | Anti-CDK3 antibody (10-90 aa) (STJ190276) | ||||||||||||||||
|